SPOCK2 and ovarian carcinoma: The established pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway shed novel insight into molecular mechanism of ovarian cancer progression and may provide effective therapeutic targets and promising prognostic biomarkers for ovarian cancer.